These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. New pharmacotherapy for Parkinson's disease. Gottwald MD; Bainbridge JL; Dowling GA; Aminoff MJ; Alldredge BK Ann Pharmacother; 1997 Oct; 31(10):1205-17. PubMed ID: 9337447 [TBL] [Abstract][Full Text] [Related]
43. 15th Annual Scientific Meeting of the Society for Biological Therapy. 26-29 October 2000, Seattle, Washington, USA. Dillman RO Expert Opin Biol Ther; 2001 Jan; 1(1):129-34. PubMed ID: 11727542 [TBL] [Abstract][Full Text] [Related]
44. Opportunities and challenges of entertainment-education: Learning about Parkinson's disease via The Michael J. Fox Show. Link E; Schluetz DM; Brauer S Commun Med; 2016; 13(2):203-214. PubMed ID: 29958362 [TBL] [Abstract][Full Text] [Related]
46. Clinical markers of neurodegeneration in Chinese patients with idiopathic rapid eye movement sleep behavior disorder. Wan Y; Luo Y; Gan J; Hu R; Zhou M; Liu Z Clin Neurol Neurosurg; 2016 Nov; 150():105-109. PubMed ID: 27614794 [TBL] [Abstract][Full Text] [Related]
47. Increasing Efficiency of Recruitment in Early Parkinson's Disease Trials: A Case Study Examination of the STEADY-PD III Trial. Berk S; Greco BL; Biglan K; Kopil CM; Holloway RG; Meunier C; Simuni T J Parkinsons Dis; 2017; 7(4):685-693. PubMed ID: 29103052 [TBL] [Abstract][Full Text] [Related]
48. The Movement Disorder Society--14th International Congress of Parkinson's Disease and Movement Disorders. Grosset D; Grosset A IDrugs; 2010 Aug; 13(8):539-42. PubMed ID: 20721824 [TBL] [Abstract][Full Text] [Related]
49. Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort. Fereshtehnejad SM; Montplaisir JY; Pelletier A; Gagnon JF; Berg D; Postuma RB Mov Disord; 2017 Jun; 32(6):865-873. PubMed ID: 28429825 [TBL] [Abstract][Full Text] [Related]
51. Parkinson's Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms. Mu J; Chaudhuri KR; Bielza C; de Pedro-Cuesta J; Larrañaga P; Martinez-Martin P Front Aging Neurosci; 2017; 9():301. PubMed ID: 28979203 [TBL] [Abstract][Full Text] [Related]
52. Palliative care and Parkinson's disease: Meeting summary and recommendations for clinical research. Kluger BM; Fox S; Timmons S; Katz M; Galifianakis NB; Subramanian I; Carter JH; Johnson MJ; Richfield EW; Bekelman D; Kutner JS; Miyasaki J Parkinsonism Relat Disord; 2017 Apr; 37():19-26. PubMed ID: 28108265 [TBL] [Abstract][Full Text] [Related]
53. Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study. Bjørnarå KA; Pihlstrøm L; Dietrichs E; Toft M BMC Neurol; 2018 Feb; 18(1):20. PubMed ID: 29466944 [TBL] [Abstract][Full Text] [Related]
54. Rising to the Challenges of Clinical Trial Improvement in Parkinson's Disease. Mathur S; DeWitte S; Robledo I; Isaacs T; Stamford J J Parkinsons Dis; 2015; 5(2):263-8. PubMed ID: 25720445 [TBL] [Abstract][Full Text] [Related]